
|Articles|March 10, 2017
Pharmacy Week in Review: March 10, 2017
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Advertisement
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pembrolizumab Combination FDA-Approved for Ovarian Cancer
2
In Mississippi’s Maternal Health Crisis, Pharmacies Become Lifelines
3
Study Finds No Statistically Significant Difference in Efficacy, Safety Between Intranasal Ketamine and IV Morphine
4
Research Suggests Caffeinated Coffee or Tea Could Reduce Dementia Risk
5







































